Ectopic TGF beta 1 expression in the secretory mammary epithelium induces early senescence of the epithelial stem cell population.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMID 7883078)

Published in Dev Biol on March 01, 1995

Authors

E C Kordon1, R A McKnight, C Jhappan, L Hennighausen, G Merlino, G H Smith

Author Affiliations

1: Laboratory of Tumor Immunology and Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892-1750.

Articles citing this

Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2006) 6.64

Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci U S A (1995) 2.79

Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J Cell Biol (2003) 2.68

Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Mol Cell Biol (2003) 1.99

Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev (2009) 1.95

Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation. Am J Pathol (2002) 1.88

Cyclin D1 determines mitochondrial function in vivo. Mol Cell Biol (2006) 1.75

TGF-beta biology in mammary development and breast cancer. Cold Spring Harb Perspect Biol (2011) 1.75

Murine mammary epithelial stem cells: discovery, function, and current status. Cold Spring Harb Perspect Biol (2011) 1.63

ETV6-NTRK3 fusion oncogene initiates breast cancer from committed mammary progenitors via activation of AP1 complex. Cancer Cell (2007) 1.53

Elf5 is essential for early embryogenesis and mammary gland development during pregnancy and lactation. EMBO J (2005) 1.52

Isolation and characterization of functional mammary gland stem cells. Cell Prolif (2003) 1.49

Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol (2003) 1.46

Transforming growth factor-beta can suppress tumorigenesis through effects on the putative cancer stem or early progenitor cell and committed progeny in a breast cancer xenograft model. Cancer Res (2007) 1.42

IL1- and TGFβ-Nox4 signaling, oxidative stress and DNA damage response are shared features of replicative, oncogene-induced, and drug-induced paracrine 'bystander senescence'. Aging (Albany NY) (2012) 1.32

Loss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype. Breast Cancer Res (2009) 1.29

Transforming growth factor-beta and breast cancer: Mammary gland development. Breast Cancer Res (2000) 1.26

Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res (2008) 1.20

Identification of Stem Cell Units in the Terminal End Bud and Duct of the Mouse Mammary Gland. J Biomed Biotechnol (2001) 1.20

Transforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression. J Mammary Gland Biol Neoplasia (2009) 1.15

Epithelial progenitor cell lines as models of normal breast morphogenesis and neoplasia. Cell Prolif (2003) 1.15

Transforming growth factor-beta and breast cancer: Lessons learned from genetically altered mouse models. Breast Cancer Res (2000) 1.02

Tumour-stromal interactions. Transforming growth factor-beta isoforms and hepatocyte growth factor/scatter factor in mammary gland ductal morphogenesis. Breast Cancer Res (2001) 1.02

TGF-β family signaling in stem cells. Biochim Biophys Acta (2012) 1.01

Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Am J Pathol (2005) 0.99

Functional characterization of stem cell activity in the mouse mammary gland. Stem Cell Rev (2011) 0.98

Wnt5a as an effector of TGFβ in mammary development and cancer. J Mammary Gland Biol Neoplasia (2011) 0.96

Transforming growth factor-alpha promotes mammary tumorigenesis through selective survival and growth of secretory epithelial cells. Am J Pathol (1995) 0.95

TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol (2009) 0.91

Choreographing metastasis to the tune of LTBP. J Mammary Gland Biol Neoplasia (2011) 0.90

IFNγ induces oxidative stress, DNA damage and tumor cell senescence via TGFβ/SMAD signaling-dependent induction of Nox4 and suppression of ANT2. Oncogene (2015) 0.90

The mammary gland microenvironment directs progenitor cell fate in vivo. Int J Cell Biol (2011) 0.85

Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling. Dev Dyn (2012) 0.82

Chemotherapeutic Targeting of the Transforming Growth Factor-β Pathway in Breast Cancers. Breast Cancer Manag (2015) 0.79

Epithelial stem cells in the mammary gland: casting light into dark corners. Breast Cancer Res (1999) 0.78

Development of Foreign Mammary Epithelial Morphology in the Stroma of Immunodeficient Mice. PLoS One (2013) 0.78

Cripto-1 Ablation Disrupts Alveolar Development in the Mouse Mammary Gland through a Progesterone Receptor-Mediated Pathway. Am J Pathol (2015) 0.77

A TGFβ-miR-182-BRCA1 axis controls the mammary differentiation hierarchy. Sci Signal (2016) 0.76

Telomerase and estrogen-sensing activities are essential for continued mammary growth in vivo but dispensable for "reprogramming" neural stem cells. Aging (Albany NY) (2016) 0.75

Original Research: Featured Article: Imatinib mesylate (Gleevec) inhibits Notch and c-Myc signaling: Five-day treatment permanently rescues mammary development. Exp Biol Med (Maywood) (2016) 0.75

Ltbp1L is focally induced in embryonic mammary mesenchyme, demarcates the ductal luminal lineage and is upregulated during involution. Breast Cancer Res (2013) 0.75

Articles by these authors

The Families and Genera of the Bacteria: Preliminary Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types. J Bacteriol (1917) 10.16

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet (1999) 8.17

Notch signaling is essential for vascular morphogenesis in mice. Genes Dev (2000) 6.88

Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci U S A (1994) 5.71

Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell (1984) 5.61

Stat5a is mandatory for adult mammary gland development and lactogenesis. Genes Dev (1997) 5.57

The Families and Genera of the Bacteria: Final Report of the Committee of the Society of American Bacteriologists on Characterization and Classification of Bacterial Types. J Bacteriol (1920) 5.56

The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene (2000) 4.90

Cre-mediated gene deletion in the mammary gland. Nucleic Acids Res (1997) 4.89

An entire functional mammary gland may comprise the progeny from a single cell. Development (1998) 4.77

PRODUCTION OF PULMONARY INFARCTS BY THE INSUFFLATION OF ACID. J Exp Med (1920) 4.54

EFFECT OF INTRABRONCHIAL INSUFFLATION OF ACID. J Exp Med (1920) 4.17

TGF alpha overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell (1990) 3.86

Antibodies to human c-myc oncogene product: evidence of an evolutionarily conserved protein induced during cell proliferation. Science (1984) 3.63

Spatial and temporal expression of the Cre gene under the control of the MMTV-LTR in different lines of transgenic mice. Transgenic Res (2001) 3.45

Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol (1999) 3.04

The variability in activity of the universally expressed human cytomegalovirus immediate early gene 1 enhancer/promoter in transgenic mice. Nucleic Acids Res (1991) 2.93

Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89

Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue. Proc Natl Acad Sci U S A (1995) 2.79

Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J (1986) 2.62

Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands. Genes Dev (1992) 2.59

Mammary epithelial cells undergo secretory differentiation in cycling virgins but require pregnancy for the establishment of terminal differentiation. Development (1995) 2.50

Morphological and cytochemical studies on lymphocytic choriomeningitis virus. J Virol (1968) 2.46

The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev (1998) 2.25

Neonatal sunburn and melanoma in mice. Nature (2001) 2.25

Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci U S A (1987) 2.23

Establishment and characterization of differentiated, nontransformed hepatocyte cell lines derived from mice transgenic for transforming growth factor alpha. Proc Natl Acad Sci U S A (1994) 2.20

Distribution of intracisternal A-particles in a variety of normal and neoplastic mouse tissues. Int J Cancer (1971) 2.19

Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A (1997) 2.12

Conditional deletion of the Bcl-x gene from erythroid cells results in hemolytic anemia and profound splenomegaly. Development (2000) 2.10

Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res (1993) 2.09

Expression of a dominant-negative mutant TGF-beta type II receptor in transgenic mice reveals essential roles for TGF-beta in regulation of growth and differentiation in the exocrine pancreas. EMBO J (1997) 2.08

Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J (1998) 2.07

Interaction of protein with DNA in vitro. Methods Enzymol (1987) 2.07

Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol (2001) 2.05

An indirect effect of Stat5a in IL-2-induced proliferation: a critical role for Stat5a in IL-2-mediated IL-2 receptor alpha chain induction. Immunity (1997) 2.01

Use of enzyme-labeled antibody for electron microscope localization of lymphocytic choriomeningitis virus antigens in infected cell cultures. J Natl Cancer Inst (1969) 2.01

High-affinity binding site for a specific nuclear protein in the human IgM gene. Nature (1985) 2.00

Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.92

Expression of a truncated Int3 gene in developing secretory mammary epithelium specifically retards lobular differentiation resulting in tumorigenesis. Cancer Res (1996) 1.90

Transgenic factor VIII: the milky way and beyond. Nat Biotechnol (1997) 1.88

Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol (1996) 1.86

Targeting expression of a transforming growth factor beta 1 transgene to the pregnant mammary gland inhibits alveolar development and lactation. EMBO J (1993) 1.86

Expression of a whey acidic protein transgene during mammary development. Evidence for different mechanisms of regulation during pregnancy and lactation. J Biol Chem (1991) 1.84

Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science (1996) 1.82

Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A (1997) 1.80

Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol (1995) 1.79

Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate-early gene. J Virol (1988) 1.78

Effect of the depth and width of the urethral plate on tubularized incised plate urethroplasty. J Urol (2000) 1.77

MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene (2000) 1.74

Analysis of genetic instability during mammary tumor progression using a novel selection-based assay for in vivo mutations in a bacteriophage lambda transgene target. Proc Natl Acad Sci U S A (1996) 1.73

Surgical experience in the management of spontaneous pneumothorax, 1972-82. Thorax (1983) 1.69

Three division-competent, structurally-distinct cell populations contribute to murine mammary epithelial renewal. Tissue Cell (1997) 1.68

Malignant melanoma: modern black plague and genetic black box. Genes Dev (1998) 1.67

Renal cysts in transgenic mice expressing transforming growth factor-alpha. J Lab Clin Med (1994) 1.66

Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Dev Biol (2001) 1.66

Deficiency in mouse oxytocin prevents milk ejection, but not fertility or parturition. J Neuroendocrinol (1996) 1.62

Constitutive expression of a truncated INT3 gene in mouse mammary epithelium impairs differentiation and functional development. Cell Growth Differ (1995) 1.62

GLUT8 is a glucose transporter responsible for insulin-stimulated glucose uptake in the blastocyst. Proc Natl Acad Sci U S A (2000) 1.60

Comparison of the regulation of the whey acidic protein gene with that of a hybrid gene containing the whey acidic protein gene promoter in transgenic mice. Mol Endocrinol (1988) 1.59

Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype. Mol Cell Biol (1996) 1.59

Surgical management of the nonpalpable testis: the Children's Hospital of Philadelphia experience. J Urol (1998) 1.57

Cell-specific activity of the modulator region in the human cytomegalovirus major immediate-early gene. Mol Cell Biol (1989) 1.55

DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nat Genet (1997) 1.55

c-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res (1998) 1.54

Some Properties of Staphylococcus Toxin. Yale J Biol Med (1940) 1.54

Reducing mammary cancer risk through premature stem cell senescence. Oncogene (2001) 1.54

Colony stimulating factor 1 is required for mammary gland development during pregnancy. Proc Natl Acad Sci U S A (1994) 1.53

STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression. Blood (1997) 1.53

Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity. Eur Heart J (1992) 1.52

A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice. Proc Natl Acad Sci U S A (1988) 1.49

Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene (2008) 1.48

Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro. Mol Cell Biol (1988) 1.47

EPITHELIAL PROLIFERATION FOLLOWING THE INTRABRONCHIAL INSUFFLATION OF ACID. J Exp Med (1920) 1.45

Adverse hemodynamic effects of pericardial closure soon after open heart operation. Ann Thorac Surg (1992) 1.45

Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats. Physiol Genomics (2005) 1.43

Bcl-x and Bax regulate mouse primordial germ cell survival and apoptosis during embryogenesis. Mol Endocrinol (2000) 1.42

Mammary epithelial stem cells: our current understanding. J Mammary Gland Biol Neoplasia (1999) 1.41

The Thermostability of Staphylococcus Toxins. Yale J Biol Med (1941) 1.41

Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. Mech Dev (2001) 1.40

Selected topics in drug information access and practice: an update. Ann Pharmacother (1994) 1.38

Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Cell Growth Differ (1999) 1.38

Communication breakdown: a preventable cause of acute renal failure in a newborn infant. Med J Aust (1996) 1.38

Nuclear proteins from lactating mammary glands bind to the promoter of a milk protein gene. Nucleic Acids Res (1987) 1.37

Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology (1992) 1.36

The activities of 2-oxoglutarate dehydrogenase and pyruvate dehydrogenase in hearts and mammary glands from ruminants and non-ruminants. Biochem J (1977) 1.36

Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ (1996) 1.36

Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest (1996) 1.33

The microarray explorer tool for data mining of cDNA microarrays: application for the mammary gland. Nucleic Acids Res (2000) 1.30

Valvotomy in calcific mitral stenosis. Br Heart J (1970) 1.30